X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5507) 5507
Book Chapter (146) 146
Publication (43) 43
Dissertation (25) 25
Conference Proceeding (10) 10
Book / eBook (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
disease activity (3642) 3642
science & technology (3449) 3449
life sciences & biomedicine (3426) 3426
humans (3240) 3240
female (2511) 2511
male (2385) 2385
rheumatology (2190) 2190
adult (2021) 2021
middle aged (1998) 1998
rheumatoid arthritis (1615) 1615
severity of illness index (1453) 1453
aged (1136) 1136
systemic lupus erythematosus (753) 753
adolescent (579) 579
treatment outcome (547) 547
medicine & public health (496) 496
arthritis (483) 483
antirheumatic agents - therapeutic use (449) 449
quality of life (433) 433
young adult (432) 432
arthritis, rheumatoid - drug therapy (429) 429
disease progression (412) 412
patients (402) 402
biomarkers - blood (387) 387
abridged index medicus (378) 378
immunology (377) 377
analysis (361) 361
prospective studies (351) 351
care and treatment (346) 346
rheumatoid factor (337) 337
lupus (331) 331
surveys and questionnaires (328) 328
cross-sectional studies (326) 326
gastroenterology & hepatology (313) 313
prognosis (313) 313
medical research (303) 303
ankylosing spondylitis (299) 299
inflammation (299) 299
risk factors (291) 291
arthritis, rheumatoid - physiopathology (290) 290
case-control studies (288) 288
follow-up studies (288) 288
child (284) 284
medicine, experimental (278) 278
arthritis, rheumatoid - diagnosis (270) 270
retrospective studies (269) 269
aged, 80 and over (257) 257
remission (255) 255
cohort studies (250) 250
ulcerative colitis (234) 234
biomarkers (231) 231
arthritis, rheumatoid - blood (230) 230
treatment (230) 230
disease-activity (229) 229
enzyme-linked immunosorbent assay (229) 229
c-reactive protein (226) 226
crohn's disease (225) 225
inflammatory bowel disease (225) 225
disease activity score (222) 222
diagnosis (220) 220
predictive value of tests (219) 219
blood sedimentation (218) 218
time factors (215) 215
remission induction (212) 212
reproducibility of results (212) 212
disability evaluation (208) 208
lupus erythematosus, systemic - blood (202) 202
health risk assessment (196) 196
research (195) 195
general & internal medicine (194) 194
skin and connective tissue diseases (194) 194
medicine, general & internal (192) 192
health status (189) 189
clinical trials (184) 184
internal medicine (184) 184
medicine (181) 181
multiple sclerosis (181) 181
psoriatic arthritis (181) 181
activities of daily living (176) 176
studies (176) 176
research article (171) 171
lupus erythematosus, systemic - immunology (170) 170
musculoskeletal diseases (170) 170
longitudinal studies (169) 169
magnetic resonance imaging (167) 167
1506 (166) 166
sensitivity and specificity (163) 163
lupus erythematosus, systemic - physiopathology (162) 162
pain (161) 161
neurosciences & neurology (158) 158
c-reactive protein - analysis (157) 157
lupus erythematosus, systemic - diagnosis (152) 152
clinical medicine (149) 149
cytokines (148) 148
diseases of the musculoskeletal system (146) 146
prevalence (142) 142
original (140) 140
drug therapy (135) 135
c-reactive protein - metabolism (132) 132
disease (131) 131
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5032) 5032
Japanese (332) 332
Chinese (126) 126
German (79) 79
Turkish (39) 39
Korean (36) 36
Russian (36) 36
Portuguese (35) 35
Spanish (30) 30
French (25) 25
Czech (17) 17
Polish (15) 15
Italian (13) 13
Persian (12) 12
Norwegian (4) 4
Hungarian (3) 3
Lithuanian (2) 2
Slovak (2) 2
Swedish (2) 2
Arabic (1) 1
Croatian (1) 1
Dutch (1) 1
Indonesian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Watanabe, Kenji and Matsumoto, Takayuki and Hisamatsu, Tadakazu and Nakase, Hiroshi and Motoya, Satoshi and Yoshimura, Naoki and Ishida, Tetsuya and Kato, Shingo and Nakagawa, Tomoo and Esaki, Motohiro and Nagahori, Masakazu and Matsui, Toshiyuki and Naito, Yuji and Kanai, Takanori and Suzuki, Yasuo and Nojima, Masanori and Watanabe, Mamoru and Hibi, Toshifumi and Andoh, Akira and Ashida, Toshifumi and Endo, Katsuya and Endo, Yutaka and Fujita, Hiroshi and Fujiya, Mikihiro and Haruma, Ken and Hiraoka, Sakiko and Hirata, Ichiro and Honda, Yutaka and Iijima, Hideki and Iizuka, Bunei and Ikeya, Kentaro and Inoue, Takuya and Inoue, Syuji and Ishiguro, Yo and Ishihara, Shyunji and Ito, Hiroaki and Iwakiri, Ryuichi and Kagaya, Takashi and Kashida, Hiroshi and Kato, Shingo and Kato, Jun and Katsurada, Takehiko and Kinjyo, Fukunori and Kobayashi, Kiyonori and Kodama, Mayumi and Kunisaki, Reiko and Kurahara, Koichi and Kurokami, Takafumi and Kyouwon, Lee and Matsuda, Koichiro and Matsueda, Kazuhiro and Matsui, Toshiyuki and Mitsuyama, Keiichi and Mizokami, Yuji and Motoya, Satoshi and Nakamura, Shiro and Nojima, Masanori and Nomura, Masafumi and Ogawa, Atsuhiro and Okazaki, Kazuichi and Otsuka, Kazuaki and Sakuraba, Hirotake and Saruta, Masayuki and Sasaki, Makoto and Shirai, Takayuki and Suga, Tomoaki and Sugimura, Kazuhito and Sugiyama, Toshiro and Takeshima, Fuminao and Tamaki, Hiroyuki and Tanaka, Shinji and Tanida, Satoshi and Tominaga, Keiichi and Tomizawa, Taku and Watababe, Kenji and Yamamoto, Syojiro and Yamashita, Masaki and Yoshida, Atsushi and DIAMOND study group and DIAMOND study grp
Clinical gastroenterology and hepatology, ISSN 1542-3565, 04/2018, Volume 16, Issue 4, pp. 542 - 549.e1
We previously reported results from a prospective randomized controlled trial comparing the efficacy of adalimumab monotherapy versus combination with... 
Narrowing | DIAMOND Trial | Ileocolonoscopy | Crohn’s Disease Activity Index | Crohn's Disease Activity Index | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Index Medicus
Journal Article
Egyptian Rheumatology and Rehabilitation, ISSN 1110-161X, 10/2019, Volume 46, Issue 4, pp. 269 - 277
Objective To study the utility of the Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5) as a valid tool for daily rheumatoid arthritis (RA) monitoring... 
Clinical Disease Activity Index | Rheumatoid Arthritis Disease Activity Index-5 | Disease Activity Score 28
Journal Article
Multiple sclerosis and related disorders, ISSN 2211-0348, 07/2015, Volume 4, Issue 4, pp. 329 - 333
Journal Article
Indian Journal of Rheumatology, ISSN 0973-3698, 7/2019, Volume 14, Issue 3, pp. 206 - 210
Background: Most patients coming to government hospital are from lower socioeconomic class and do not always get investigations done like ESR or CRP. A purely... 
disease activity | disease activity score employing 28 joint count-c-reactive protein | clinical disease activity index | disease activity score employing 28 joint count-erythrocyte sedimentation rate | rheumatoid arthritis
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 2012, Volume 87, Issue 7, pp. 659 - 673
Abstract The past decade has brought important advances in the understanding of rheumatoid arthritis and its management and treatment. New classification... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Prognosis | Humans | Methotrexate - therapeutic use | Arthritis, Rheumatoid - complications | Abatacept | Time Factors | Arthritis, Rheumatoid - drug therapy | Synovitis - etiology | Anti-Inflammatory Agents - therapeutic use | Immunoconjugates - therapeutic use | Antirheumatic Agents - pharmacology | Drug Therapy, Combination | Arthritis, Rheumatoid - diagnosis | Arthritis, Rheumatoid - physiopathology | Antirheumatic Agents - therapeutic use | Biological Products - therapeutic use | Severity of Illness Index | Sulfasalazine - therapeutic use | Diagnosis, Differential | Antibodies, Monoclonal, Humanized - therapeutic use | Anti-Inflammatory Agents - pharmacology | Comorbidity | Rituximab | Joints - pathology | Treatment Outcome | Evidence-Based Medicine | Remission Induction | Arthritis, Rheumatoid - pathology | Randomized Controlled Trials as Topic | Arthritis, Rheumatoid - therapy | Quality of Life | Referral and Consultation | Isoxazoles - therapeutic use | Prednisone - therapeutic use | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Causes of | Practice guidelines (Medicine) | Care and treatment | Diagnosis | Rheumatoid arthritis | Patient outcomes | Index Medicus | Abridged Index Medicus | ACPA, anti–citrullinated protein antibody | TNF, tumor necrosis factor | BeSt, Behandel-Strategieën [trial] | CDAI, Clinical Disease Activity Index | SSZ, sulfasalazine | MTX, methotrexate | EULAR, European League Against Rheumatism | HCQ, hydroxychloroquine | TEAR, Treatment of Early Aggressive Rheumatoid Arthritis [study] | DMARD, disease-modifying antirheumatic drug | ACR, American College of Rheumatology | CRP, C-reactive protein | Diagnosis and Treatment Guidelines | My treatment approach | CTLA-4:Ig, cytotoxic T lymphocyte–associated antigen 4:immunoglobulin fusion protein | DAS28, Disease Activity Score in 28 joints | SDAI, Simplified Disease Activity Index
Journal Article
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 12/2017, Volume 76, Issue 12, pp. e54 - e54
The EULAR recommendations for the management of fibromyalgia are based on more than 100 reviews and meta-analyses of individual therapies and medicines. 1... 
disease activity | treatment | patient perspective | Life Sciences & Biomedicine | Rheumatology | Science & Technology | Fibromyalgia | Index Medicus
Journal Article
Rheumatology (Oxford, England), ISSN 1462-0324, 2004, Volume 43, Issue 10, pp. 1252 - 1255
Journal Article
Annals of the rheumatic diseases, ISSN 0003-4967, 03/2017, Volume 76, Issue 3, pp. 554 - 561
Journal Article